These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23334525)

  • 21. [Helpful instrumental examinations in idiopathic Parkinson's disease].
    Walter U; Zach H; Liepelt-Scarfone I; Maetzler W
    Nervenarzt; 2017 Apr; 88(4):365-372. PubMed ID: 28289798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Magnetic resonance imaging in Parkinson's disease--the evaluation of the width of pars compacta on T2 weighted image].
    Moriwaka F; Tashiro K; Itoh K; Hamada T; Miyasaka K
    Rinsho Shinkeigaku; 1992 Jan; 32(1):8-12. PubMed ID: 1628441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion tensor imaging differentiates vascular parkinsonism from parkinsonian syndromes of degenerative origin in elderly subjects.
    Deverdun J; Menjot de Champfleur S; Cabello-Aguilar S; Maury F; Molino F; Charif M; Leboucq N; Ayrignac X; Labauge P; Bonafe A; Castelnovo G; Le Bars E; Geny C; Menjot de Champfleur N
    Eur J Radiol; 2014 Nov; 83(11):2074-9. PubMed ID: 25154005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes.
    Clarke CE; Lowry M
    Eur J Neurol; 2001 Nov; 8(6):573-7. PubMed ID: 11784341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imaging.
    Gröger A; Kolb R; Schäfer R; Klose U
    PLoS One; 2014; 9(1):e84081. PubMed ID: 24416192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
    Federico F; Simone IL; Lucivero V; Iliceto G; De Mari M; Giannini P; Mezzapesa DM; Tarantino A; Lamberti P
    Mov Disord; 1997 Nov; 12(6):903-9. PubMed ID: 9399213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.
    Georgiopoulos C; Davidsson A; Engström M; Larsson EM; Zachrisson H; Dizdar N
    J Neurol; 2015 Sep; 262(9):2154-63. PubMed ID: 26122543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3T.
    Vafaeyan H; Ebrahimzadeh SA; Rahimian N; Alavijeh SK; Madadi A; Faeghi F; Harirchian MH; Rad HS
    Australas Phys Eng Sci Med; 2015 Dec; 38(4):611-8. PubMed ID: 26526449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of cerebral microbleeds in idiopathic Parkinson's disease.
    Kim JH; Park J; Kim YH; Ma HI; Kim YJ
    Eur J Neurol; 2015 Feb; 22(2):377-83. PubMed ID: 25367411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Usefulness of SPECT and MRI in the diagnosis of atypical parkinsonism].
    Skogseid IM; Gerdts R; Nyberg-Hansen R; Rootwelt K; Bakke SJ
    Tidsskr Nor Laegeforen; 2001 Nov; 121(29):3399-403. PubMed ID: 11826785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinguishing idiopathic Parkinson's disease from other parkinsonian syndromes by breath test.
    Nakhleh MK; Badarny S; Winer R; Jeries R; Finberg J; Haick H
    Parkinsonism Relat Disord; 2015 Feb; 21(2):150-3. PubMed ID: 25511331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson's disease and Atypical Parkinsonian syndromes using DaTSCAN® SPECT.
    Davidsson A; Georgiopoulos C; Dizdar N; Granerus G; Zachrisson H
    Ann Nucl Med; 2014 Nov; 28(9):851-9. PubMed ID: 24997753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease.
    Cosottini M; Frosini D; Pesaresi I; Costagli M; Biagi L; Ceravolo R; Bonuccelli U; Tosetti M
    Radiology; 2014 Jun; 271(3):831-8. PubMed ID: 24601752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease.
    Zhou B; Yuan F; He Z; Tan C
    Brain Imaging Behav; 2014 Mar; 8(1):97-101. PubMed ID: 23955491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.
    Al-Bachari S; Parkes LM; Vidyasagar R; Hanby MF; Tharaken V; Leroi I; Emsley HC
    Neuroimage Clin; 2014; 6():1-8. PubMed ID: 25379411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson's disease from atypical parkinsonian disorders.
    Jaimini A; Tripathi M; D'Souza MM; Panwar P; Sharma R; Mehta S; Pandey S; Saw S; Singh D; Solanki Y; Mishra AK; Mondal A
    Nucl Med Commun; 2013 May; 34(5):426-31. PubMed ID: 23458855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease.
    Stoffers D; Booij J; Bosscher L; Winogrodzka A; Wolters EC; Berendse HW
    Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):689-95. PubMed ID: 15682332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging.
    Ohtsuka C; Sasaki M; Konno K; Kato K; Takahashi J; Yamashita F; Terayama Y
    Parkinsonism Relat Disord; 2014 Jul; 20(7):755-60. PubMed ID: 24768616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of cerebral metabolism by multi-voxel proton magnetic resonance spectroscopy imaging in chronic unilateral internal carotid artery occlusion].
    Takayama H; Suga S; Kobayashi M; Sadanaga F; Hozumi A; Kanai Y; Okamura M; Mihara B
    No To Shinkei; 2000 Apr; 52(4):307-12. PubMed ID: 10793417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The usage of proton magnetic resonance spectroscopy in Parkinson's disease.
    Metarugcheep P; Hanchaiphiboolkul S; Viriyavejakul A; Chanyawattiwongs S
    J Med Assoc Thai; 2012 Jul; 95(7):949-52. PubMed ID: 22919991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.